Ramzi Khamis
0000-0003-4119-5193
Organisation
73 papers found
Refreshing results…
Female Gender and Coronary Intervention Are Significant Risk Factors for Cardiac Catheterisation-Related Stroke in a Tertiary Centre Experience Over a Three Year Period
A NOVEL IGG AUTOANTIBODY, LO9, REACTS SPECIFICALLY WITH ADHERENT LOW DENSITY LIPOPROTEIN (LDL), TARGETS LDL IN ATHEROSCLEROSIS IN VIVO AND STIMULATES MACROPHAGE TNFα RELEASE
High Serum Immunoglobulin G and M Levels Improve Cardiovascular Risk Discrimination in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial
Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis
Time-Trend Analyses of Bleeding and Mortality After Primary Percutaneous Coronary Intervention During Out of Working Hours Versus In-Working Hours
FRI0250 Coronary CT-Angiography Reveals the Extent of Coronary Artery Disease in Takayasu Arteritis:
A novel immunoglobulin G autoantibody against a cryptic epitope in low density lipoprotein (LDL) revealed in atherosclerosis
A Novel Immunoglobulin G Autoantibody Against a Cryptic Epitope in Low Density Lipoprotein Induces Macrophage Tumour Necrosis Factor Release
TCT-28 Comparison Of Outcomes For Primary Percutaneous Coronary Intervention During Out Of Working Hours Versus In Working Hours: An Observational Cohort Study Of 11,461 Patients
223 A Novel Immunoglobulin G Autoantibody Against Low Density Lipoprotein (LDL) with Pathogenic Functions
C Development of Whole Body and Intravascular Near-infrared Optical Molecular Imaging of Markers of Plaque Vulnerablity in Atherosclerosis
Near-Infrared Fluorescence (Nirf) Whole Body and Intra-Arterial Molecular Imaging of Oxidized Ldl in Experimental Atherosclerosis
Disturbed Flow Promotes Endothelial Senescence via a p53-Dependent Pathway
The Near Infra-Red (NIRF) molecular imaging of oxidised LDL in atherosclerosis with the native autoantibody LO1, and its molecularly expressed cysteine-tagged Fab construct (LO1-Fab-cys)
Dissecting the protective IgG anti-malondialdehyde-LDL (MDA-LDL) antibody response in a substudy of the Anglo Scandinavian Cardiac Outcomes Trial (ASCOT)
Yia1: Imaging Beyond the Lumen: Near Infra-Red in Vivo Molecular Identification of Oxidised Ldl in Atherosclerosis Using Mab Lo1, and the Generation and Development of Its Molecularly Expressed Cysteine-Tagged Chimeric Fab Construct (Lo1-Fab-Cys)
165 Scavenger Receptors Mediate Uptake of Modified Ldl by Circulating Blood Monocyte Subsets: Consequences for Atherosclerosis.
The ASCOT Anti-oxidised LDL Antibodies Substudy, IgG Anti-malondialdehyde-ldl Antibodies are Independent Predictors of Protection From Cardiovascular Events in a Substudy of the Anglo-scandinavian Cardiac Outcomes Trial
The Development of LO1, a Novel IgG Monoclonal Natural Antibody, for the Near Infra-Red (NIRF) Imaging of Oxidised LDL in Atherosclerosis
Abstract 15370: The Development of LO1, a Novel IgG Monoclonal Natural Antibody, for the Near Infra-Red (NIRF) Imaging of Oxidised LDL in Atherosclerosis
Missing publications? Search for publications with a matching author name.